19 related articles for article (PubMed ID: 8080264)
1. Induction of cytochrome P450 1A1 gene expression by a vitamin K3 analog in mouse hepatoma Hepa-1c1c7 cells.
Chun YJ; Lee BY; Yang SA; Ryu CK; Kim MY
Mol Cells; 2001 Oct; 12(2):190-6. PubMed ID: 11710520
[TBL] [Abstract][Full Text] [Related]
2. Identification of 3'-methoxy-4'-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells.
Lu YF; Santostefano M; Cunningham BD; Threadgill MD; Safe S
Arch Biochem Biophys; 1995 Jan; 316(1):470-7. PubMed ID: 7840652
[TBL] [Abstract][Full Text] [Related]
3. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
Astroff B; Zacharewski T; Safe S; Arlotto MP; Parkinson A; Thomas P; Levin W
Mol Pharmacol; 1988 Feb; 33(2):231-6. PubMed ID: 2828916
[TBL] [Abstract][Full Text] [Related]
4. 6-substituted 3,4-benzocoumarins: a new structural class of inducers and inhibitors of CYP1A1-dependent activity.
Liu H; Santostefano M; Lu Y; Safe S
Arch Biochem Biophys; 1993 Oct; 306(1):223-31. PubMed ID: 8215408
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of aryl hydrocarbon receptor antagonists: inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression.
Merchant M; Morrison V; Santostefano M; Safe S
Arch Biochem Biophys; 1992 Nov; 298(2):389-94. PubMed ID: 1329656
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of action of alpha-naphthoflavone as an inhibitor of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression.
Merchant M; Arellano L; Safe S
Arch Biochem Biophys; 1990 Aug; 281(1):84-9. PubMed ID: 2166479
[TBL] [Abstract][Full Text] [Related]
7. 2-Phenylphenanthridinone and related compounds: aryl hydrocarbon receptor agonists and suicide inactivators of P4501A1.
Liu H; Santostefano M; Safe S
Arch Biochem Biophys; 1994 Sep; 313(2):206-14. PubMed ID: 8080264
[TBL] [Abstract][Full Text] [Related]
8. Dose-response and risk assessment considerations for receptor-mediated effects: case study with a TCDD hepatic tumor promotion model.
Sewall CH; Lucier GW
Prog Clin Biol Res; 1994; 387():155-71. PubMed ID: 7972245
[No Abstract] [Full Text] [Related]
9. A model of effects of TCDD on expression of rat liver proteins.
Kohn MC; Portier CJ
Prog Clin Biol Res; 1994; 387():211-22. PubMed ID: 7972248
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
